BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Information Letter on Fiasp® (insulin aspart): new colour scheme for cartridges and pre-filled pens

Active substance: insulin aspart

The company Novo Nordisk Pharma GmbH is circulating information on the fact that a new colour scheme will be introduced for Fiasp® products as of July 2018 in order to improve their discernibility from Tresiba®.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 291KB, File is accessible

Use of cookies

Cookies help us to provide our services. By using our website you agree that we can use cookies. Read more about our Privacy Policy and visit the following link: Privacy Policy (only in German)

OK